Home » Trials » SLCTR/2012/009


Study of efficacy between two combinations of herbal medicine (amukkirai chooranam / vellarugu chooranam with thalangai ennai) in the treatment of knee osteoarthritis

-

SLCTR Registration Number

SLCTR/2012/009


Date of Registration

17 Sep 2012

The date of last modification

Mar 03, 2019


Trial Status



Application Summary


Scientific Title of Trial

Study of efficacy between two combinations of herbal medicine (amukkirai chooranam / vellarugu chooranam with thalangai ennai) in the treatment of knee osteoarthritis


Public Title of Trial

Study of the combination of amukkirai chooranam with thalangai ennai and vellarugu chooranam with thalangai ennai in the treatment of knee osteoarthritis


Disease or Health Condition(s) Studied

Knee Osteoarthritis


Scientific Acronym

None


Public Acronym

None


Brief title

None


Universal Trial Number

None


Any other number(s) assigned to the trial and issuing authority

None


Trial Details


What is the research question being addressed?

Which combination of herbal medicine: amukkirai chooranam with thalangai ennai or vellarugu chooranam with thalangai ennai is more efficacious in the treatment of knee osteoarthritis?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Masking not used


Control

Active


Assignment

Parallel


Purpose

Treatment


Study Phase

Not Available


Intervention(s) planned

Patients will be recruited for the trial following qualitative and quantitative analysis of the trial medicines (Amukkirai and Vellarugu chooranam) and a pilot study. Subjects for the clinical trial will be selected from Out Patients Department (O.P.D.) and Indoor Patients Department (I.P.D.) of Ayurvedic Hospitals / Dispensaries in Jaffna District. Eligible patients with knee osteoarthritis will be randomized in a 1:1 ratio to the treatment arms. The prescribed dose is two capsules thrice a day with lukewarm water after meals. The daily dose of experimental medicine is 3g (Each capsule contains 500mg of trial plant materials) and local applications of oil {10ml} twice a day for one mandalam (40 days). Subjects will be requested to refrain from other alternative medicinal therapy (allopathic, homeopathy, acupuncture, and acupressure, etc.) during the study period.


Inclusion criteria

  1. Subjects suffering from knee osteoarthritis diagnosed based on history, clinical examination findings and classical radiological findings, and fulfilling the American College of Rheumatology (ACR) classification criteria 2. Age above 40 years 3. Pain visual analogue score (VAS) > 4 in one or both the knees while performing a weight bearing activity 4. Ambulant and require analgesic for pain relief and / or not satisfied with ongoing analgesic drugs and seeking a change

Exclusion criteria

  1. Subjects with non-degenerative joint diseases or other joint diseases such as ?ma v?ta (rheumatoid arthritis), Kazhugazha v?ta, (psoriatic arthritis), Piramega v?ta (gonococcal arthritis), Narithalai v?ta (haemo arthritis) 2. Subjects with severe disabling arthritis and / or bedridden. 3. History of intra-articular knee injection within the month preceding the study 3. Severe unstable renal, hepatic, diabetic, haemopoietic, malignant, hypertensive, cardiac disorder and mentally affected as revealed by history and / or investigation. 4. Subject taking antipyretics, analgesics, tranquilizers, hypnotics, alcohol, or any other drug which would interfere with pain perception and need for other drug therapy for arthritis 5. Women who are pregnant, lactating 6. Those unwilling to come for regular follow-up for the entire duration of the study.


Primary outcome(s)

1.

Traditional clinical parameters {Prakriti assessment, eight fold examination and six fold source of knowledge}

[

At baseline, 10th, 20th, 30th, 40th days, and on follow-up assessment at the end of one month and two months.

]
2.

Clinical parameters: gait, knee joint pain {Visual Analogue Scale (VAS)}, stiffness, tenderness on knee joint, knee joint swelling, muscular wasting (a tape measure), local crepitation, walking time, restriction of knee joint movement, range of knee joint movements (Goniometer assessment), knee joint deformities and muscular power.

[

At baseline, 10th, 20th, 30th, 40th days, and on follow-up assessment at the end of one month and two months.

]

Secondary outcome(s)

1.

The effect of morbidity status on health related quality of life in subjects will be measured by the WOMAC questionnaire, goniomter assessment and Visual analogue Scale. Questionnaire will be used to assess pain, stiffness and physical functions depending on score basis. Movements and pain will be measured by goniometer and VAS scale respectively.

[

At baseline and immediately after end of therapy (40th day) then follow-up period at the end of one month and two months.

]
2.

Routine laboratory workup (haemoglobin, White blood cell - total and differential count, Erythrocyte sedimentation rate, Rheumatoid factor assays, Liver function test and Kidney function test} and X-rays of knees

[

At baseline and immediately after end of therapy (40th day) then follow-up period at the end of one month and two months.

]

Target number/sample size

300


Countries of recruitment

Sri Lanka


Anticipated start date

2012-09-18


Anticipated end date

2015-01-01


Date of first enrollment

2013-02-21


Date of study completion


Recruitment status

Recruiting


Funding source

Scholarship award for M’Phil / PhD, Higher Education for the Twenty first Century (HETC) Project, Ministry of Higher Education, Sri Lanka


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2012-07-12


Approval number

J/ERC/12/29//DR/0007


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medicine, University of Jaffna
Institutional Address:ERC Office, Faculty of Medicine, University of Jaffna, Adiyapatham Road, Kokuvil, Jaffna Sri Lanka
Telephone:+94-212222073 (Extension: 342)
Email: ercmedjfn@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Dr. (Miss) Vinotha Sanmugarajah
Lecturer (Probationary)
Unit of Siddha Medicine, University of Jaffna, Kaithady

0777490634


Contact Person for Public Queries

Dr. (Mrs) Sri Ranjani Sivapalan
(supervisor) Senior Lecturer Gr.I
Unit of Siddha Medicine, University of Jaffna, Kaithady
0212225673
0777171656



Primary study sponsor/organization

HETC Project, Ministry of Higher Education, Sri Lanka.

23/135 Diyawanna Gardens, Chandra Silva MW, Nugegoda
0094 11 2814283, 0094 11 2814279

hrd@hetc.lk
www.hetc.lk

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results